SCHEMBL2808147

SCHEMBL2808147

Fc1ccccc1C1Cc2cnc(Nc3cccc(CCN4CCNCC4)c3)nc2-c2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.66
CSF1R P07333 1/20 0.66
FGFR2 P21802 1/20 0.66
FGFR3 P22607 1/20 0.66
SYK P43405 1/20 0.41
PLK1 P53350 4/20 0.40
ABL1 P00519 1/20 0.40
BCR P11274 1/20 0.40
KDR P35968 5/20 0.39
CDK1 P06493 3/20 0.39
CDK2 P24941 4/20 0.39
CDK9 P50750 4/20 0.39
PTK2 Q05397 1/20 0.38
SLC6A4 P31645 2/20 0.37
CCNT1 O60563 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK7 P50613 1/20 0.37
CCNH P51946 1/20 0.37
CCNA1 P78396 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2490696 1.00 FGFR1 (0.66) FGFR1CSF1RFGFR2FGFR3SYK
Hydrochloric Acid SCHEMBL2807775 0.99 FGFR1 (0.65) FGFR1CSF1RFGFR2FGFR3SYK
Hydrochloric Acid SCHEMBL2489792 0.99 FGFR1 (0.65) FGFR1CSF1RFGFR2FGFR3SYK
SCHEMBL13273589 0.92 FGFR1 (0.70) FGFR1CSF1RFGFR2FGFR3PLK1
Hydrochloric Acid SCHEMBL2574175 0.91 FGFR1 (0.69) FGFR1CSF1RFGFR2FGFR3PLK1
Hydrochloric Acid SCHEMBL2803505 0.91 FGFR1 (0.69) FGFR1CSF1RFGFR2FGFR3PLK1
SCHEMBL2489606 0.88 CSF1R (0.78) FGFR1CSF1RFGFR2FGFR3PLK1
SCHEMBL2489609 0.88 CSF1R (0.78) FGFR1CSF1RFGFR2FGFR3PLK1
SCHEMBL2806250 0.88 CSF1R (0.78) FGFR1CSF1RFGFR2FGFR3PLK1
Hydrochloric Acid SCHEMBL2806569 0.87 CSF1R (0.76) FGFR1CSF1RFGFR2FGFR3PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885CSF1R 4606/4885FGFR2 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.